BioNxt Solutions Inc. (BNXT) | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 10/29/2024 at 08:10, 5 days 5 hours ago

BioNxt avance dans ses démarches de dépôt de brevets pour un nouveau mode d'administration de médicaments

Sclérose En Plaques Solutions BioNxt Myasthénie Grave Médicaments Sublinguaux Dépôts De Brevets
BRIEF

published on 10/29/2024 at 08:10, 5 days 5 hours ago

BioNxt Advances Patent Filings for Novel Drug Delivery

Multiple Sclerosis Patent Filings BioNxt Solutions Myasthenia Gravis Sublingual Drugs
PRESS RELEASE

published on 10/29/2024 at 08:05, 5 days 5 hours ago

BioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases
BioNxt Solutions Inc. initiates nationalization process for sublingual anticancer drug patents for autoimmune neurodegenerative diseases. Positive report from European Patent Office on patentability

BioNxt Solutions Inc. Patents Anticancer Drugs Sublingual Delivery Autoimmune Neurodegenerative Diseases
BRIEF

published on 10/07/2024 at 09:10, 27 days 4 hours ago

Terry Lynch rejoint BioNxt Solutions en tant que conseiller en marchés financiers

Sclérose En Plaques Marchés Des Capitaux Solutions BioNxt Terry Lynch Cladribine Sublinguale
BRIEF

published on 10/07/2024 at 09:10, 27 days 4 hours ago

Terry Lynch Joins BioNxt Solutions as Capital Markets Advisor

Capital Markets Multiple Sclerosis BioNxt Solutions Terry Lynch Sublingual Cladribine
PRESS RELEASE

published on 10/07/2024 at 09:05, 27 days 4 hours ago

Terry Lynch Joins BioNxt as Capital Markets Advisor
BioNxt Solutions Inc. appoints Terry Lynch, a capital markets advisor with extensive experience in resource and bioscience sectors. Mr. Lynch joins the team to support the development and commercialization of the sublingual Cladribine product for MS treatment

BioNxt Solutions Inc. Terry Lynch Sublingual Cladribine Capital Markets Advisor MS Treatment
BRIEF

published on 09/26/2024 at 09:10, 1 month 7 days ago

BioNxt Provides Update on Cladribine Program for Multiple Sclerosis

Investor Relations Multiple Sclerosis Cladribine BioNxt Solutions Patent Approval
BRIEF

published on 09/26/2024 at 09:10, 1 month 7 days ago

BioNxt fait le point sur son programme de cladribine pour la sclérose en plaques

Sclérose En Plaques Relations Avec Les Investisseurs Cladribine Solutions BioNxt Approbation Du Brevet
PRESS RELEASE

published on 09/26/2024 at 09:05, 1 month 7 days ago

BioNxt Provides Update on Cladribine Program for Multiple Sclerosis, Sublingual Neurodegenerative Disease Patent, and Investor Relations Activities
BioNxt Solutions Inc. updates on sublingual Cladribine drug formulation program for Multiple Sclerosis, patent applications, and investor relations activities. Company aims to revolutionize drug delivery systems for CNS diseases

Investor Relations BioNxt Solutions Inc. Multiple Sclerosis Cladribine Patent Application
BRIEF

published on 09/09/2024 at 22:35, 1 month 23 days ago

BioNxt Receives Positive International Examination Report From the European Patent Office

Multiple Sclerosis BioNxt Solutions European Patent Office Sublingual Drug Delivery Myasthenia Gravis

1 2 ... 7

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 25 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 17 hours 55 minutes ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 21 hours ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 40 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 19 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE